Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Jul;29(7):1308–1311. doi: 10.1128/jcm.29.7.1308-1311.1991

Detection of human papillomavirus DNA in genital lesions by using a modified commercially available in situ hybridization assay.

M P Meyer 1, C A Markiw 1, R R Matuscak 1, A Saker 1, K McIntyre-Seltman 1, A J Amortegui 1
PMCID: PMC270106  PMID: 1653262

Abstract

A modified, commercially available DNA-DNA in situ hybridization test that uses biotinylated probes for the identification of human papillomavirus (HPV) DNA types 6/11, 16/18, and 31/33/35 was evaluated. HPV DNA was detected in 314 of 787 (40%) histologically abnormal genital biopsy specimens by using the ViraType in situ assay (Life Technologies, Gaithersburg, Md.), in which the hybridization time was increased from 2 to 16 h. Ninety percent of positive condyloma acuminata specimens contained HPV type 6/11 DNA. The prevalences of HPV DNA for cervical intraepithelial neoplasia I, II, and III lesions by this in situ hybridization test were 42, 54, and 55%, respectively. The combined prevalence of HPV type 16/18 and 31/33/35 DNAs increased with the severity of the lesion, while the prevalence of type 6/11 DNA decreased. HPV type 6/11 DNA was found only in 1 of 16 (6%) positive cervical intraepithelial neoplasia III specimens. HPV type 16/18 and 31/33/35 DNA was detected in 11 of 16 (69%) and 4 of 16 (25%) in situ hybridization-positive cervical intraepithelial neoplasia III specimens, respectively. Thus, the observation that certain "higher-risk" HPV genotypes are associated with upper-grade cervical precancer lesions was confirmed by this commercial hybridization system. In general, the assay was found to be well suited for use in the clinical laboratory. The ViraType in situ procedure modified for a longer hybridization time may be helpful in identifying lesions containing higher-risk HPV strains.

Full text

PDF
1308

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amortegui A. J., Meyer M. P., McIntyre-Seltman K., Locker J. Detection of human papillomavirus DNA in cervical lesions by in situ hybridization using biotinylated DNA probes. Int J Gynecol Pathol. 1990;9(4):306–315. doi: 10.1097/00004347-199010000-00002. [DOI] [PubMed] [Google Scholar]
  2. Czeglédy J., Gergely L., Hernádi Z., Póka R. Detection of human papillomavirus deoxyribonucleic acid in the female genital tract. Med Microbiol Immunol. 1989;178(6):309–314. doi: 10.1007/BF00197449. [DOI] [PubMed] [Google Scholar]
  3. Macnab J. C., Walkinshaw S. A., Cordiner J. W., Clements J. B. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med. 1986 Oct 23;315(17):1052–1058. doi: 10.1056/NEJM198610233151703. [DOI] [PubMed] [Google Scholar]
  4. McCance D. J., Campion M. J., Clarkson P. K., Chesters P. M., Jenkins D., Singer A. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol. 1985 Nov;92(11):1101–1105. doi: 10.1111/j.1471-0528.1985.tb03019.x. [DOI] [PubMed] [Google Scholar]
  5. Millan D. W., Davis J. A., Torbet T. E., Campo M. S. DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) 1986 Jul 12;293(6539):93–96. doi: 10.1136/bmj.293.6539.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nuovo G. J., Richart R. M. A comparison of biotin- and 35S-based in situ hybridization methodologies for detection of human papillomavirus DNA. Lab Invest. 1989 Oct;61(4):471–476. [PubMed] [Google Scholar]
  7. Nuovo G. J., Richart R. M. A comparison of slot blot, southern blot, and in situ hybridization analyses for human papillomavirus DNA in genital tract lesions. Obstet Gynecol. 1989 Oct;74(4):673–678. [PubMed] [Google Scholar]
  8. Reeves W. C., Brinton L. A., García M., Brenes M. M., Herrero R., Gaitán E., Tenorio F., de Britton R. C., Rawls W. E. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med. 1989 Jun 1;320(22):1437–1441. doi: 10.1056/NEJM198906013202201. [DOI] [PubMed] [Google Scholar]
  9. Richart R. M. Causes and management of cervical intraepithelial neoplasia. Cancer. 1987 Oct 15;60(8 Suppl):1951–1959. doi: 10.1002/1097-0142(19901015)60:8+<1951::aid-cncr2820601505>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Schneider A., Sawada E., Gissmann L., Shah K. Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol. 1987 Apr;69(4):554–562. [PubMed] [Google Scholar]
  11. Syrjänen K. J. Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. Med Biol. 1987;65(1):21–39. [PubMed] [Google Scholar]
  12. Syrjänen K. J. Human papillomavirus (HPV) infections of the female genital tract and their associations with intraepithelial neoplasia and squamous cell carcinoma. Pathol Annu. 1986;21(Pt 1):53–89. [PubMed] [Google Scholar]
  13. Syrjänen S. M. Basic concepts and practical applications of recombinant DNA techniques in detection of human papillomavirus (HPV) infection. Review article. APMIS. 1990 Feb;98(2):95–110. doi: 10.1111/j.1699-0463.1990.tb01008.x. [DOI] [PubMed] [Google Scholar]
  14. Syrjänen S., Partanen P., Mäntyjärvi R., Syrjänen K. Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods. 1988 Mar-Apr;19(3-4):225–238. doi: 10.1016/0166-0934(88)90017-1. [DOI] [PubMed] [Google Scholar]
  15. Syrjänen S., Syrjänen K., Mäntyjärvi R., Parkkinen S., Väyrynen M., Saarikoski S., Castren O. Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol. 1986;239(1):39–48. doi: 10.1007/BF02134287. [DOI] [PubMed] [Google Scholar]
  16. Todd J. A., Jou L., Shen J. T., Van Dinh T., Baker V. V., Friedman A. J., Jacobs A. J., Krebs H., Posalaky Z., Runowicz C. A rapid DNA probe test for detecting human papilloma virus types 6/11 and 16 in biopsy specimens. Mol Cell Probes. 1989 Sep;3(3):273–288. doi: 10.1016/0890-8508(89)90008-x. [DOI] [PubMed] [Google Scholar]
  17. Wilbur D. C., Reichman R. C., Stoler M. H. Detection of infection by human papillomavirus in genital condylomata. A comparison study using immunocytochemistry and in situ nucleic acid hybridization. Am J Clin Pathol. 1988 Apr;89(4):505–510. doi: 10.1093/ajcp/89.4.505. [DOI] [PubMed] [Google Scholar]
  18. Yoshikawa H., Matsukura T., Yamamoto E., Kawana T., Mizuno M., Yoshiike K. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas. Jpn J Cancer Res. 1985 Aug;76(8):667–671. [PubMed] [Google Scholar]
  19. Yun K., Molenaar A. J., Wilkins R. J. Detection of human papillomavirus DNA in cervical lesions by in-situ DNA hybridization. Pathology. 1989 Jan;21(1):1–4. doi: 10.3109/00313028909059520. [DOI] [PubMed] [Google Scholar]
  20. Zhang W. H., Coppleson M., Rose B. R., Sorich E. A., Nightingale B. N., Thompson C. H., Cossart Y. E., Bannatyne P. M., Elliott P. M., Atkinson K. H. Papillomavirus and cervical cancer: a clinical and laboratory study. J Med Virol. 1988 Oct;26(2):163–174. doi: 10.1002/jmv.1890260208. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES